Remediation company contracts with five pharmaceutical companies in Pakistan, India

The company, which manufactures the experimental remediator drug for the treatment of corona virus, has entered into agreements with five pharmaceutical companies in Pakistan and India under which they can sell the drug in 127 countries around the world. Glade Sciences says that under the agreement, almost all low-income countries in the world, such as Afghanistan, North Korea, India and Pakistan, could receive the drug. Earlier, both the United States and Japan approved the use of remediators for people infected with Code 19.  Many other pharmaceutical companies are working to develop an effective drug for the treatment of cod.